Illidge T, Wilson W, Paterson J, Bates A, Cheadle E, Collins G, Cowan R, El-Mehidi N, Gallop-Evans E, James E, Adedayo T, Osborne W, O’Rourke N, Pawade J, Scarisbrick J, Ward J, Whittaker S, Morris S. Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma. haematol [Internet]. 2020Sep.10 [cited 2026Jul.25];. Available from: https://haematologica.org/article/view/14301